This fact sheet describes a phase 2 influenza vaccine clinical study that PATH and our partners are conducting in Senegal. The study seeks to better understand the performance of seasonal influenza vaccines in a tropical, low-resource region of the country. Overall, the results from this study will provide evidence to support larger research efforts to determine the most feasible and efficient ways of protecting populations in tropical, developing Africa from influenza through the use of vaccines.
Corporate author(s): PATH
Publication date: May 2013
65 KB PDF
Also known as: Évaluation del’Efficacite des Vaccins Antigrippaux Chez les Enfants du Sénégal
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Africa
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA